Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson’s disease
Radu Constantinescu(Sahlgrenska University Hospital), Henrik Zetterberg(National Hospital for Neurology and Neurosurgery), Björn Holmberg(Sahlgrenska University Hospital), Lars Rosengren(Sahlgrenska University Hospital), Olle Corneliusson(Sahlgrenska University Hospital), Bo Johnels(University of Gothenburg)
Cited by 19
Related Papers
Defeating Alzheimer's disease and other dementias: a priority for European science and society
|The Lancet Neurology|2016|1.7k
Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen
|The Lancet Neurology|2009|912
Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease Continuum
|JAMA Neurology|2021|627
A multicentre validation study of the diagnostic value of plasma neurofilament light
|Nature Communications|2021|554
A Practical Guide to Immunoassay Method Validation
|Frontiers in Neurology|2015|541